At Rejoni, we celebrate International Women's Day every day! Join us in celebrating all the women in our lives, especially our younger generation of girls!
Rejoni, Inc
医疗设备制造业
Bedford,Massachusetts 461 位关注者
Developing solutions designed to minimize the short and long-term risks associated with gynecological procedures.
关于我们
At Rejoni, our team is working on developing solutions that minimize both acute and chronic risks associated with gynecologic procedures by providing women’s health-centered technologies that help women to achieve the life they want both now and in the future.
- 网站
-
https://rejoni.com/
Rejoni, Inc的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 11-50 人
- 总部
- Bedford,Massachusetts
- 类型
- 私人持股
- 创立
- 2020
地点
-
主要
201 Burlington Rd
US,Massachusetts,Bedford,01730
Rejoni, Inc员工
动态
-
Rejoni, Inc转发了
Excited to learn of the completion of enrollment in this pivotal clinical study involving 150 patients for the prevention of Intrauterine Adhesions. Congratulations to the team at Rejoni, Inc for this significant contribution to the advancement of medical device innovation in women's health.
-
We agree! Thank you for being part of this journey!
A big congratulations to the entire Rejoni team for achieving this remarkable milestone! Onward and upward! Investing in women's health is crucial! We are one step closer to offering an effective solution for the prevention of intrauterine adhesions (IUAs). Nearly 40% of women who experience intrauterine trauma from common surgical procedures may develop adhesions. If left untreated, these adhesions can lead to difficulties in conceiving and may also cause pregnancy-related complications, such as preterm birth. https://lnkd.in/eYmxwz8a.
-
A big congratulations to the entire Rejoni team for achieving this remarkable milestone! Onward and upward! Investing in women's health is crucial! We are one step closer to offering an effective solution for the prevention of intrauterine adhesions (IUAs). Nearly 40% of women who experience intrauterine trauma from common surgical procedures may develop adhesions. If left untreated, these adhesions can lead to difficulties in conceiving and may also cause pregnancy-related complications, such as preterm birth. https://lnkd.in/eYmxwz8a.
-
Rejoni, Inc转发了
Thank you to everyone who visited us at AAGL 2024 in New Orleans! It was wonderful reconnecting with old friends and meeting many new members of the AAGL community. We look forward to seeing you in Vancouver for the 54th Annual AAGL!
-
-
Rejoni, Inc转发了
AAGL 2024 starts this Sunday evening! Be sure to visit Rejoni at booth #215. We have an exciting lineup of presentations scheduled for Monday. Here’s a sneak peek: ORAL SESSION 03 - Hysteroscopy Date: Monday, November 18, 2024 Time: 3:15 PM to 4:15 PM Room: 272 Malcolm Munro: Abstract # 12098 -The Adverse Impact of Endometrial Trauma on Pregnancy Outcomes: A Real-World Evidence Study Bala Bhagavath: Abstract # 12005 - Adverse Pregnancy Outcomes Following Intrauterine Adhesiolysis: A Systematic Review
-
-
AAGL 2024 starts this Sunday evening! Be sure to visit Rejoni at booth #215. We have an exciting lineup of presentations scheduled for Monday. Here’s a sneak peek: ORAL SESSION 03 - Hysteroscopy Date: Monday, November 18, 2024 Time: 3:15 PM to 4:15 PM Room: 272 Malcolm Munro: Abstract # 12098 -The Adverse Impact of Endometrial Trauma on Pregnancy Outcomes: A Real-World Evidence Study Bala Bhagavath: Abstract # 12005 - Adverse Pregnancy Outcomes Following Intrauterine Adhesiolysis: A Systematic Review
-
-
Rejoni is excited to announce our upcoming trip to New Orleans for the 53rd Annual AAGL Meeting next week! We invite you to visit us at booth #215, where we’ll showcase compelling clinical data emphasizing the critical importance of treating intrauterine adhesions. Don’t miss this opportunity to learn more and engage with us!
-
-
Rejoni, Inc转发了
A big thank you to all the amazing people we met during the 2024 ASRM in Denver this week. Many expressing a need to provide women seeking fertility with an effective method to prevent intrauterine adhesions. Stay tuned and continue to follow us!
-